期刊文献+

胃癌患者术前行新辅助化疗结合肠内营养支持的临床疗效观察 被引量:6

Clinical Efficacy of Preoperative Neoadjuvant Chemotherapy Combined with Enteral Nutrition Support for Gastric Cancer
下载PDF
导出
摘要 目的观察胃癌患者术前行新辅助化疗结合肠内营养支持的临床疗效。方法选取84例进展期胃癌患者为研究对象。随机分为观察组42例和对照组42例。研究组给予术前新辅助化疗结合肠内营养支持治疗,对照组仅给予术前新辅助化疗治疗。观察2组患者营养指标和免疫指标的差异及并发症的发生情况。结果治疗后观察组患者体重、白细胞数、血红蛋白、总蛋白、前清蛋白、转铁蛋白明显高于对照组,差异有统计学意义(P<0.05);观察组患者CD4水平、CD8水平和CD4/CD8明显高于对照组,差异有统计学意义,P<0.05。观察组患者治疗后胃痛、食欲不振、恶心、进食哽咽、腹胀、黑便化疗相关并发症发生率均明显低于对照组,差异有统计学意义(P<0.05)。结论胃癌患者术前行新辅助化疗结合肠内营养支持可以明显改善患者化疗后的营养状况和免疫水平,增强患者对手术的耐受力,有利于提高患者的生活质量。 Objective To observe the clinical effects of neoadjuvant chemotherapy combined with enteral nutrition support for gastric cancer. Methods 84 cases of advanced gastric cancer were randomly divided into the study group( 42 cases) and the control group( 42 cases). The study group was given preoperative neoadjuvant chemotherapy combined with enteral nutrition therapy,the control group received preoperative neoadjuvant chemotherapy treatment. The differences in nutritional,immune parameters and the occurrence of complications between the 2 groups were observed. Results After treatment,weight,white blood cell count,hemoglobin,total protein,prealbumin and transferrin of the observation group were significantly higher those of the control group,the difference was statistically significant( P〈0. 05). The levels of CD4,CD8 and CD4 / CD8 in the observation group were significantly higher than those of the control group,the difference was statistically significant,P〈0. 05. Chemotherapy related complications such as stomach pain,loss of appetite,nausea,eating choked,abdominal distension,and melena of the observation group were significantly lower than those of the control group,the difference was statistically significant( P〈0. 05). Conclusion Neoadjuvant chemotherapy combined with enteral nutrition support can significantly improve the nutritional status and immune level of patients with gastric cancer after chemotherapy. It can enhance the patient's tolerance to the operation and improve the quality of life of patients.
作者 涂铭 李林
出处 《实用癌症杂志》 2016年第7期1184-1186,1190,共4页 The Practical Journal of Cancer
关键词 胃癌 新辅助化疗 肠内营养 Gastric cancer Neoadjuvant chemotherapy Enteral nutrition
  • 相关文献

参考文献7

二级参考文献40

  • 1李乐平,靖昌庆,刘洪俊,石玉龙,林立明.新辅助化疗联合肠外营养对胃癌细胞增殖活性的影响[J].中国临床营养杂志,2006,14(2):100-103. 被引量:5
  • 2张景芳,张原平,郝风云,张采欣,李玉军,纪祥瑞.胃癌DNA倍体分析及其TIMP-2和E-cadherin在胃癌中的表达[J].中国病理生理杂志,2006,22(7):1353-1358. 被引量:2
  • 3Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:435
  • 4Wilke H, Preusser P, Fink U, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer:, a phaseII study with etoposide, doxorubicin, and cisplatin [J]. J Clin Oncol, 1989,7(9):1318-1326.
  • 5Lowy AM, Mansfield PF, Leach SD, et al. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer[J]. Ann Surg, 1999,229(3): 303-308.
  • 6Arends J, Bodoky G, Bozzetti F, et al. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology[J].Clin Nutr,2007, 26(1):161-162.
  • 7Calman KC. Quality of life in cancer patients:an hypothesis [J]. J Med Ethics, 1984,10( 3 ) : 124-127.
  • 8Wu CW, Chiou JM, Ko FS, et al. Quality of life after curative gastrec- tomy for gastric cancer in a randomised controlled trial [J]. Br J Cancer, 2008,98( 1 ) :54-59.
  • 9Yasuda K,Shiraishi N,Etoh T,et al. Long-term quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer [J]. Surg Endosc, 2007,21 (12) :2150-2153.
  • 10Tomita R,Tanjoh K,Fujisaki S. Novel operative technique for vagal nerve-and pyloric sphincter-preserving distal gastrectomy recon- structed by interposition of a 5 cm jejunal J pouch with a 3 em jejunal conduit for early gastric cancer and postoperative quality of life 5 years after operation [J ]. World J Surg, 2004,28( 8 ) : 766-774.

共引文献465

同被引文献67

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部